In the future study, administration of hemin, erastin, DOX, or other ferroptosis inducers in HMOX1−/− mice may not only provide in vivo evidence supporting the pro-ferroptotic role of HMOX1, but also help to explore the implication of ferroptosis at various stages of atherosclerosis. The gene discussed is HMOX1; the disease is atherosclerosis.